Further investigation revealed that neoantigen specific T cell was PD-1+, and the expression abundance of PD-L1 in tumor tissue was upregulated, suggesting the suppressive immune microenvironment induced by neoantigen cancer vaccine [73]. The gene discussed is PDCD1; the disease is neoplasm.